Diaceutics (LON:DXRX) Trading Down 7.1% – What’s Next?

Diaceutics PLC (LON:DXRX)’s share price was down 7.1% during trading on Tuesday . The stock traded as low as GBX 153.35 and last traded at GBX 153.35. Approximately 216,605 shares were traded during mid-day trading, an increase of 41% from the average daily volume of 153,098 shares. The stock had previously closed at GBX 165.

Diaceutics Trading Down 1.4%

The firm has a market cap of £123.56 million, a price-to-earnings ratio of -81.11 and a beta of 0.92. The company has a 50-day moving average price of GBX 161.39 and a 200 day moving average price of GBX 154.34. The company has a quick ratio of 9.92, a current ratio of 3.96 and a debt-to-equity ratio of 3.05.

Diaceutics (LON:DXRX) last issued its earnings results on Tuesday, May 26th. The company reported GBX 11 EPS for the quarter. The business had revenue of GBX 3,844 million during the quarter. Diaceutics had a negative return on equity of 3.94% and a negative net margin of 4.42%. As a group, research analysts anticipate that Diaceutics PLC will post 1.0107919 earnings per share for the current fiscal year.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.